×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Krystal Biotech doses first subject in lung cancer drug trial
Clinical Trials Arena
Krystal Biotech has dosed the first subject in the Phase I KYANITE-1 clinical trial for its inhaled oncology candidate, KB707.
1 day ago
Science
Krystal Biotech, Inc
Krystal Biotech has developed a differentiated vector platform focused on a number of indication areas including dermatology, respiratory, oncology,...
4 months ago
Krystal Biotech moves to next step in clinical trial
The Business Journals
Krystal Biotech has announced the first patient has joined a trial for its inhaled treatment for a solid lung cancer tumor.
2 days ago
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround
Yahoo Finance Canada
The heavy selling pressure might have exhausted for Krystal Biotech (KRYS) as it is technically in oversold territory now.
1 day ago
Krystal Biotech's Vyjuvek launch sparks blockbuster hopes
Fierce Pharma
Not even one year after becoming a commercial biotech, Krystal Biotech has blockbuster dreams for its flagship product.
1 month ago
Handelsbanken Fonder AB Boosts Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)
MarketBeat
Handelsbanken Fonder AB increased its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 9.2% in the fourth quarter, according to...
19 hours ago
Krystal Biotech announces first patient dosed in Phase 1 trial of KB707 - TipRanks.com
Tipranks
Krystal Biotech announced that the first patient was dosed in its Phase 1 clinical trial evaluating inhaled KB707, a modified HSV-1 vector...
3 days ago
Krystal Biotech Plans to Advance Eyedrop Gene Therapy That Cured Blindness in Teen Patient
Precision Medicine Online
Krystal Biotech Plans to Advance Eyedrop Gene Therapy That Cured Blindness in Teen Patient ... NEW YORK – Krystal Biotech aims to further develop...
1 month ago
FDA rejects Abeona' Therapeutics' topical gene therapy pz-cel
Fierce Pharma
The FDA has rejected Abeona Therapeutics' gene therapy pz-cel, specifying chemistry, manufacturing and controls (CMC) issues that must be...
1 day ago
Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene ...
Krystal Biotech, Inc
VYJUVEK is the first-ever redosable gene therapy and the first and only medicine approved by the FDA for the treatment of DEB, both recessive...
11 months ago